Hung-Ting Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hung-Ting Wu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Ta-Chiang Liu
Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St Louis, Missouri
2 shared publications Amanda Foster
Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110
1 shared publication- Andrea Santeford
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine
1 shared publication Changqing Ma
Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110
1 shared publicationChen-Ting Hung
Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110
1 shared publication- Ching-On Wong
Department of Biological Sciences, Rutgers University, Newark, NJ, USA
1 shared publication
Latest Publications
- Open Access
- 6 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
The (amide-)N-methylnicotinamide is a microbe-derived NAD + precursor that drives gut stem cell renewal
Nicotinamide Adenine Dinucleotide (NAD) is a critical cellular coenzyme whose decline associates with various chronic and inflammatory diseases. Improved NAD restoration may reduce disease risks and extend healthy lifespan. We report here that certain commensal bacteria including specific probiotic species produce (amide-)N-methylnicotinamide (N-MNA), which is a structural isomer of methylnicotinamide, a nicotinamide degradative metabolite. Patients with gut dysbiosis and inflammation show reduced stool N-MNA. Stable isotope tracing revealed that N-MNA can be rapidly taken up and incorporated into NAD redox reactions by intestinal epithelial cells (IECs) and non-IECs of fruit fly, mouse, and human. Genetic and pharmacological analyses suggest that N-MNA is converted to NAD + via the Preiss-Handler pathway, independent of the salvage pathway. Cell-type-specific ablation or overexpression of SIRT1, an NAD-consuming enzyme, in Drosophila , along with intestinal stem cell (ISC) lineage tracing in mice revealed that systemic N-MNA supplementation promotes ISC regeneration and gut epithelial repair. Compared to known NAD precursors, N-MNA brings a methyl group into host cells, representing a class of microbe-derived NAD precursor that stimulates the tissue regenerative power.
- 6 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (45)
Open AccessThe (amide-)N-methylnicotinamide is a microbe-derived NAD + precursor that drives gut stem cell renewal
Nicotinamide Adenine Dinucleotide (NAD) is a critical cellular coenzyme whose decline associates with various chronic and inflammatory diseases. Improved NAD restoration may reduce disease risks and extend healthy lifespan. We report here that certain commensal bacteria including specific probiotic species produce (amide-)N-methylnicotinamide (N-MNA), which is a structural isomer of methylnicotinamide, a nicotinamide degradative metabolite. Patients with gut dysbiosis and inflammation show reduced stool N-MNA. Stable isotope tracing revealed that N-MNA can be rapidly taken up and incorporated into NAD redox reactions by intestinal epithelial cells (IECs) and non-IECs of fruit fly, mouse, and human. Genetic and pharmacological analyses suggest that N-MNA is converted to NAD + via the Preiss-Handler pathway, independent of the salvage pathway. Cell-type-specific ablation or overexpression of SIRT1, an NAD-consuming enzyme, in Drosophila , along with intestinal stem cell (ISC) lineage tracing in mice revealed that systemic N-MNA supplementation promotes ISC regeneration and gut epithelial repair. Compared to known NAD precursors, N-MNA brings a methyl group into host cells, representing a class of microbe-derived NAD precursor that stimulates the tissue regenerative power.
- Open Access
- 9 July 2024
- Published by Elsevier in Mucosal Immunology
- Vol. 17 (5) , 1019-1028
Western diet reduces small intestinal intraepithelial lymphocytes via FXR-Interferon pathway
- 9 July 2024
- Published by Elsevier in Mucosal Immunology
- Vol. 17 (5) , 1019-1028
Open AccessWestern diet reduces small intestinal intraepithelial lymphocytes via FXR-Interferon pathway
- Open Access
- 16 January 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (4)
Catalytic isoforms of AMP-activated protein kinase differentially regulate IMPDH activity and photoreceptor neuron function
AMP-activated protein kinase (AMPK) plays a crucial role in maintaining ATP homeostasis in photoreceptor neurons. AMPK is a heterotrimeric protein consisting of α, β, and γ subunits. The independent functions of the 2 isoforms of the catalytic α subunit, PRKAA1 and PRKAA2, are uncharacterized in specialized neurons, such as photoreceptors. Here, we demonstrate in mice that rod photoreceptors lacking PRKAA2, but not PRKAA1, showed altered levels of cGMP, GTP, and ATP, suggesting isoform-specific regulation of photoreceptor metabolism. Furthermore, PRKAA2-deficient mice displayed visual functional deficits on electroretinography and photoreceptor outer segment structural abnormalities on transmission electron microscopy consistent with neuronal dysfunction, but not neurodegeneration. Phosphoproteomics identified inosine monophosphate dehydrogenase (IMPDH) as a molecular driver of PRKAA2-specific photoreceptor dysfunction, and inhibition of IMPDH improved visual function in Prkaa2 rod photoreceptor–knockout mice. These findings highlight a therapeutically targetable PRKAA2 isoform–specific function of AMPK in regulating photoreceptor metabolism and function through a potentially previously uncharacterized mechanism affecting IMPDH activity.
- 16 January 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (4)
Open AccessCatalytic isoforms of AMP-activated protein kinase differentially regulate IMPDH activity and photoreceptor neuron function
AMP-activated protein kinase (AMPK) plays a crucial role in maintaining ATP homeostasis in photoreceptor neurons. AMPK is a heterotrimeric protein consisting of α, β, and γ subunits. The independent functions of the 2 isoforms of the catalytic α subunit, PRKAA1 and PRKAA2, are uncharacterized in specialized neurons, such as photoreceptors. Here, we demonstrate in mice that rod photoreceptors lacking PRKAA2, but not PRKAA1, showed altered levels of cGMP, GTP, and ATP, suggesting isoform-specific regulation of photoreceptor metabolism. Furthermore, PRKAA2-deficient mice displayed visual functional deficits on electroretinography and photoreceptor outer segment structural abnormalities on transmission electron microscopy consistent with neuronal dysfunction, but not neurodegeneration. Phosphoproteomics identified inosine monophosphate dehydrogenase (IMPDH) as a molecular driver of PRKAA2-specific photoreceptor dysfunction, and inhibition of IMPDH improved visual function in Prkaa2 rod photoreceptor–knockout mice. These findings highlight a therapeutically targetable PRKAA2 isoform–specific function of AMPK in regulating photoreceptor metabolism and function through a potentially previously uncharacterized mechanism affecting IMPDH activity.